COMMUNIQUÉS West-GlobeNewswire
-
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
09/03/2026 -
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
09/03/2026 -
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
09/03/2026 -
The Right to Religious Exemption to Vaccination Upheld in Court, according to the Journal of American Physicians and Surgeons
09/03/2026 -
Tonix Pharmaceuticals Presented Data on TONMYA™ in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
09/03/2026 -
Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results
09/03/2026 -
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
09/03/2026 -
Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
09/03/2026 -
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
09/03/2026 -
COVID mRNA Vaccines May Alter Gene Expression, according to Journal of American Physicians and Surgeons
09/03/2026 -
SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
09/03/2026 -
Slim Force BHB Ketone Claims Evaluated: 2026 Consumer Research Report on SlimForce Ingredients, Ketogenic Supplement Positioning, and What Adults Should Verify Before Purchasing
09/03/2026 -
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026
09/03/2026 -
Novonesis named a Great Employer to Work For in North Carolina
09/03/2026 -
President of the Association of American Physicians and Surgeons (AAPS) Calls for Physician Stewardship
09/03/2026 -
Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology
09/03/2026 -
Direct Meds GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors
09/03/2026 -
Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas
09/03/2026 -
TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations
09/03/2026
Pages